Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06385886

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once unaffiliated individuals are found using the pathways, Investigators will employ linkage coordinators (trained staff) to engage these patients in care. Participants will be asked to fill out an assessment survey which will cover areas such as previous and current treatment, clinic and hospital experience, pain, and quality of life. Participants will also be given the option of participation in a 1-hour long interview how they feel about treatment for sickle cell disease including clinic experience, pain, and quality of life?

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Alabama, Birmingham (UAB), Birmingham, Alabama, United States

Loading trial locations.

About this study

The goal of RECIPE (Recruitment and Engagement in Care to Impact Practice Enhancement) for Sickle Cell Disease is to find unaffiliated patients with SCD using three distinct pathways (Community, Hospital, Surveillance) engage them in care using linkage coordinators (LCs; a successful method adapted from HIV care), and understand the contextual factors and implementation support needed to ensure these methodologies can be further scaled up at a national level. This study is significant because information about unaffiliated patients with SCD who are not actively engaged in the health system has not been systematically collected and studied in the past. Information comes only from experienced clinicians, community groups, patient advocates, and word of mouth. The lack of data about this population is problematic because current implementation studies focus on the barriers related to affiliated patients, with no known strategies identified to engage unaffiliated patients. No previous studies have evaluated the best methods for locating and then engaging and maintaining unaffiliated patients in specialty SCD care. This study will contribute to the literature by optimizing different pathways for finding unaffiliated patients, as well as providing evidence on what may work best in different clinical care settings and among different patients to address barriers to care in hard-to-reach populations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Persons must be >/= 18 years of age
  • Persons must have confirmed SCD
  • Persons not seen by a SCD specialist > 1 year +/- 3 months
  • Literacy in English will be required of the consenting patient or parent/guardian

Exclusion criteria

  • Persons < 18 years of age
  • Persons that are unable to provide informed consent and do not have a designated care-giver that can consent on his/her behalf
  • Persons with sickle cell trait (as per hemoglobin electrophoresis)
  • Persons seen by a SCD specialist < 1 year +/1 3 months

Treatment and study plan

Linkage Coordinator

Behavioral

The Linkage Coordinator (LC) will be the initial contact with unaffiliated SCD patients to establish a relationship, champion preventative services, and support them in engaging with an SCD specialist by helping patients address barriers to care. Study staff will provide initial and ongoing training to the LC to ensure they have adequate support to effectively engage with patients.

Primary outcomes

  1. Identification of unaffiliated patients

    Time frame: Beginning of enrollment - end of study (up to 5 years)

    Identification of patients through hospital, surveillance, and community-based pathways.

  2. Affiliation with a Sickle cell disease (SCD)-specific care with SCD specialist

    Time frame: Beginning of enrollment - end of study (up to 5 years)

    Rate of affiliation of participants previously unaffiliated with SCD-specific care with an SCD specialist who are now connected to a linkage coordinator and an SCD-specific care with SCD specialist.

Secondary outcomes

  1. Scale Out to Other SCD Centers - Implementation in at least 2 other SCD Center study sites

    Time frame: After methods are optimized - end of study (up to 5 years)

    Once investigators optimize methods for finding and engaging unaffiliated patients with SCD, it is necessary to expand efforts to other SCD sites. The study will expand to include 2 additional sites and begin to assess rate of affiliation of participants previously unaffiliated with SCD-specific care with an SCD specialist who are now connected to a linkage coordinator and an SCD-specific care with SCD specialist.

Study contacts

Contact information is provided by the study sponsor or research team.

Lisa A Cox, MS

CONTACT

[email protected]

770-407-4908

Sara Jacobs, PhD

CONTACT

[email protected]

770-407-4951

Sponsors and collaborators

Lead sponsor

RTI International

Other

Registry information

Acronym: RECIPE

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Apr 26, 2024
Registry last updated
Jun 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.